Treatment of Mood Disorders: Summary
As knowledge expands about the influence of psychiatric illness on the medically ill, more is learned about specific treatment of mood disorders, which affects prognosis, morbidity,…

Treatment of Mood Disorders: Neoplasm
The rates of depression among patients with cancer range from 1.5% to 50%, depending on the location of the primary tumor. The highest prevalence of…

Treatment of Mood Disorders: Pulmonary Diseases
The occurrence of depression in patients with chronic obstructive pulmonary disease (COPD) has been found to be approximately 45%. The selection of an…

Treatment of Mood Disorders: Diabetes Mellitus
The high prevalence of psychiatric illness in the diabetic population has been significantly evaluated only in recent years. In a study of 114…

Treatment of Mood Disorders: Neurological Illnesses
Cerebrovascular accident and Parkinson’s disease are two neurological illnesses associated with a high incidence of comorbid depression after initial neurological insult. Within a…

Treatment of Mood Disorders: Renal Disease
It is unclear whether psychiatric illness or specific mood disorders are related to renal disease or to the psychological distress associated with dialysis…

Treatment of Mood Disorders: Rheumatoid Arthritis
Depressive symptoms occur in 17%-27% of patients with rheumatoid arthritis. One study compared the prevalence of a psychiatric diagnosis in patients with musculoskeletal…

Treatment of Mood Disorders: Specific Medical Illnesses

Cardiovascular Disease
Exciting progress has been made involving the relationship of coronary artery disease (CAD) and depression. Among patients with CAD,…

Treatment of Mood Disorders: Psychotherapy
Although the Agency for Health Care Policy and Research has published a set of practice guidelines on depression in the primary care/medically ill sector that…

Treatment of Mood Disorders: Electroconvulsive Therapy
Electroconvulsive therapy (ECT) is an often-used modality in the treatment of mood disorders with comorbid medical problems. ECT generally has been reserved for…

Treatment of Mood Disorders: Psychostimulants
Psychostimulants have been used effectively in the treatment of depression in patients with illnesses that vary from stroke to HIV. Psychostimulants exert their effect in rapid…

Treatment of Mood Disorders: Monoamine Oxidase Inhibitors
Monoamine oxidase inhibitors (MAOIs) are another class of antidepressant that is effective, but they possess other properties limiting their use in…

Treatment of Mood Disorders: Tricyclic Antidepressants
Although no longer considered as first-line therapy, TCAs are still commonly used as initial treatment because of their familiarity. This heterocyclic class includes…

Treatment of Mood Disorders: Newer and Atypical Antidepressant Agents and the Cytochrome System
Newer antidepressants including venlafaxine (a phenylpiperazine), nefazodone (a phenylethylamine), and mirtazapine (a piperazino-azepine) have…

Pharmacological Selection for Medically Ill Patients
Selective Serotonin Reuptake Inhibitors and the Cytochrome P450 System

In recent years the antidepressant class of choice in medically ill patients has been…

Introduction

The incidence of comorbid mood disorders and general medical illness has been shown to have…